Where is Avidity Biosciences headquartered?

Avidity Biosciences is located in La Jolla, CA.

Who invested in Avidity Biosciences?

Avidity Biosciences has 13 investors including Geekdom Fund And Geekdom Fund.

How much funding has Avidity Biosciences raised to date?

Avidity Biosciences has raised ____.

When was the last funding round for Avidity Biosciences?

Avidity Biosciences closed its lastf unding roundon Jul 19, 2017 from a Convertible Note round.

Company Information
Company Timeline (Coming Soon)

aviditybiosciences.com

Avidity Biosciences

Avidity Biosciences develops and markets oligonucleotide-based therapeutics to treat muscle disorders.

Business Model:

Revenue: $8.4M

Employees: 51-200

Geographic Data

Address: 10975 N Torrey Pines Road

City: La Jolla

State: CA

Zip: 92037

Country: US

Financial Info

Stage:

series c

Raised Last:

$100M

Raised Total:

$140M

Social

Twitter

Crunchbase

Metrics

1,412,143Website Global Rank

19,251Website Monthly Traffic

Twitter Followers

Description

Avidity Biosciences develops and markets oligonucleotide-based therapeutics to treat muscle disorders.

Contact Phone:
+18584017900

Contact Email:

IPO Details

Avidity Biosciences went public on 6/11/2020 on the NASDAQ

Listed Exchange:
NASDAQ

IPO Date:
6/11/2020

IPO Valuation:
$636M

Ticker Symbol:
RNA

IPO Price:
$18/share

Amount Raised:
$298M

Live

Opened: -/share

EBITDA	-
Total Cash	-
Total Debt	-
Total Revenue	-
Total Profit (Gross)	-
PE Ratio	-

Investments

Announced Date	Company	Transaction	Money Raised

Funding Rounds

Announced Date	Transaction	Number of Investors	Money Raised	Lead Investors
10/2018	Series B		$0	Takeda Alethea Capital Management Alexandria Real Estate Equities Brace Pharma EcoR1 Capital F-Prime Capital Moore Venture Partners Tavistock Life Sciences Takeda Alethea Capital Management Alexandria Real Estate Equities Brace Pharma EcoR1 Capital F-Prime Capital Moore Venture Partners Tavistock Life Sciences
12/2016	Series B		$16M	Takeda Ventures, Inc. Alethea Capital Alexandria Real Estate Equities BracePharma EcoR1 Capital F-Prime Capital Moore Venture Partners Tavistock Life Sciences
6/2020	IPO		$259.2M
4/2019	Venture Round	1	$15M	Eli Lilly Eli Lilly
10/2014	Convertible Note		$6M	TPG Biotech Brace Pharma Partner Fund Management, L.P
11/2019	Series C		$0	Perceptive Advisors Takeda Ventures Eli Lilly Logos Capital Partner Fund Management CureDuchenne Ventures RTW Investments LLC Cormorant Asset Management Brace Pharma Alethea Capital Management RTW Investments LLC Perceptive Advisors Takeda Ventures Eli Lilly Logos Capital Partner Fund Management CureDuchenne Ventures RTW Investments LLC Cormorant Asset Management Brace Pharma Alethea Capital Management RTW Investments LLC
1/2014	Venture Round	1	-	Eight Roads Ventures Eight Roads Ventures
2/2014	Series A		$9.1M
10/2018	Equity		-
12/2022	Post-IPO Equity		$207M
11/2019	Series C	10	$100M	RTW Investments CureDuchenne Logos Capital Perceptive Advisors LLC ST Pharm Alethea Capital Alexandria Venture Investments Boxer Capital Brace Pharma Capital EcoR1 Capital Partner Fund Management Takeda Ventures Eli Lilly and Company Perceptive Advisors Takeda Ventures Eli Lilly Logos Capital Partner Fund Management CureDuchenne Ventures RTW Investments LLC Cormorant Asset Management Brace Pharma Alethea Capital Management RTW Investments LLC
10/2018	Equity		-	CureDuchenne CureDuchenne
10/2018	Series B	8	$16M	Takeda Takeda
1/2014	Venture Round	1	-	Eight Roads Ventures Eight Roads Ventures

Acquisitions

Announced Date	Name	Price

Employee Demographics

Employee Departments

Employee States

Similar Companies

Uniview Singapore VEID	Revenue: 0 - 100000 Employees: Industry: Software	Details
Konkuk University Medical Center	Revenue: 0 - 100000 Employees: 51 - 500 Industry: Education	Details
Daemon Technologies	Revenue: 0 - 100000 Employees: 1 - 10 Industry: Blockchain	Details
Ace International Trade	Revenue: 0 - 100000 Employees: 11 - 50 Industry: Industrial	Details
An Hòa Communications	Revenue: 0 - 100000 Employees: 1 - 10 Industry: Advertising	Details